Takizawa, Tsubasa
Ihara, Keiko
Watanabe, Narumi
Takemura, Ryo
Takahashi, Nobuyuki
Miyazaki, Naoki
Shibata, Mamoru
Suzuki, Keisuke
Imai, Noboru
Suzuki, Norihiro
Hirata, Koichi
Takeshima, Takao
Nakahara, Jin
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K15693)
unrestricted research grants
Article History
Received: 25 January 2024
Accepted: 23 February 2024
First Online: 15 March 2024
Declarations
:
: This study was approved by the Ethics Committee of the Keio University School of Medicine (approval no. 20221100). Participants were informed about the purpose and the content of the study through the online survey form. The need for informed consent was waived by the Ethics Committee of the Keio University School of Medicine in accordance with national regulations (Ethical Guidelines for Medical and Biological Research Involving Human Subjects).
: Not applicable.
: TsT is a consultant/advisor and/or serves on an advisory board for Eli Lilly, Otsuka, Amgen, Pfizer, and Teijin and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, Amgen, Kowa, Kyowa Kirin, Eisai, UCB Japan, Takeda, and Santen Pharmaceutical and grant/funding from Eli Lilly, Pfizer and Tsumura outside the submitted work. MS has received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen, and Otsuka Pharmaceutical Co., Ltd. KSĀ has received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen, and Otsuka Pharmaceutical Co., Ltd. NI reports being an advisor for Sawai and has received speaker fees from Daiichi Sankyo, Eli Lilly, Otsuka, and Amgen. NS has received speaker honoraria from Otsuka and Daiichi Sankyo. KH is a consultant/advisor for Otsuka and Sawai and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, and Amgen. TaT is a consultant/advisor for Hedgehog MedTech and Sawai and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, and Amgen. JN has received honoraria and research scholarships from Amgen and Daiichi Sankyo.